戻る Agenda
Artificial Intelligence in Drug Discovery and Development: Emerging Technologies and Applications
Session Chair(s)
Scott Spangler, MA
Distinguished Engineer, Chief Data Scientist for Life Sciences
IBM Watson, United States
Learning Objective : Describe translatable experiences and practices concerning impactful applications of artificial intelligence.
Speaker(s)
Panelist: Activity Metabolomics and ArtificiaI Predictions
Erica Majumder, PHD
Scripps Research, United States
Postdoctoral Research Fellow, Center for Mass Spectrometry and Metabolomics
Challenges and Opportunities in Near-Term Quantum Computation
Yudong Cao, PHD, MS
Zapata Computing, United States
Co-founder and CTO
Panelist
Craig Lipset, MPH
Decentralized Trials & Research Alliance | Buffalo Initiative, United States
Co-Chair